The study, published in Journal of the National Cancer Institute, followed 40,000 Scottish women who received the HPV vaccine between ages 12 and 13 and were born between 1988 and 1996.
The women, currently between the ages of 28 and 36, have had no cases of cervical cancer and have 2.5 times lower chances of developing the cancer compared to unvaccinated populations.
The study was spearheaded by researchers at Public Health Scotland.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
